← Back to Search

LLS Program Services for Blood Cancer

N/A

Waitlist Available

Led By Frank Penedo, PhD

Research Sponsored by University of Miami

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 month, 6 month

Awards & highlights

No Placebo-Only Group

Summary

This trial will study how the Leukemia & Lymphoma Society helps patients with blood cancer access care, improve quality of life, & reduce financial burden.

Who is the study for?

This trial is for blood cancer patients currently undergoing treatment who have unmet needs that the Leukemia and Lymphoma Society's (LLS) Program aims to address. Participants must speak English or Spanish, not be using LLS services already, and agree to a 6-month follow-up.

What is being tested?

The study evaluates how the LLS Program affects blood cancer patients' access to care, quality of life, and financial burden. It seeks to understand if these services fill gaps in their current care regimen over a six-month period.

What are the potential side effects?

Since this trial involves participation in support programs rather than medical treatments, there are no direct physical side effects associated with traditional clinical interventions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 month, 6 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 month, 6 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 month, 6 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in number of care needs as measured by the Access to Care Survey

Change in number of medication access problems as measured by the Access to Care Survey

Secondary study objectives

Change in financial toxicity as measured by FACIT-COST

Change in general health-related quality of life (HRQL)

Change in treatment satisfaction as measured by FACIT

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: LLS Program and Usual Care GroupExperimental Treatment1 Intervention

Participants in the LLS Program and Usual Care condition will receive LLS services such as information, services, and financial aid so that patients can have better access to healthcare and better quality of life. Participants will also receive the standard care. Participants will be in this group for 6 months.

Group II: Usual Care GroupActive Control1 Intervention

Participants will receive the standard care. Participants will be in this group for 6 months.

Do I qualify?Apply below to find out